Detalle Publicación

ARTÍCULO

Efficacy and Safety of Sorafenib in Combination With Mammalian Target of Rapamycin Inhibitors for Recurrent hepatocellular Carcinoma After Liver Transplantation

Autores: Gómez-Martín, Carlos; Bustamante, Javier; Castroagudin, Javier F.; Salcedo, Magdalena; Garralda, Elena; Testillano, Milagros; Herrero Santos, José Ignacio; Matilla, Ana; Sangro Gómez-Acebo, Bruno Carlos
Título de la revista: Liver Transplantation
ISSN: 1527-6465
Volumen: 18
Número: 1
Páginas: 45 - 52
Fecha de publicación: 2012
Resumen:
There is currently no consensus on the most suitable treatment for the recurrence of hepatocellular carcinoma (HCC) after liver transplantation. This open, multicenter, retrospective, uncontrolled cohort study was designed to evaluate the safety and preli
DOI: https://doi.org/10.1002/lt.22434
Impacto:
127 citas en
Google Scholar